Literature DB >> 29355077

The COP9 signalosome inhibits Cullin-RING E3 ubiquitin ligases independently of its deneddylase activity.

Annabelle Suisse1, Miklós Békés2, Tony T Huang2, Jessica E Treisman1.   

Abstract

The COP9 signalosome inhibits the activity of Cullin-RING E3 ubiquitin ligases by removing Nedd8 modifications from their Cullin subunits. Neddylation renders these complexes catalytically active, but deneddylation is also necessary for them to exchange adaptor subunits and avoid auto-ubiquitination. Although deneddylation is thought to be the primary function of the COP9 signalosome, additional activities have been ascribed to some of its subunits. We recently showed that COP9 subunits protect the transcriptional repressor and tumor suppressor Capicua from two distinct modes of degradation. Deneddylation by the COP9 signalosome inactivates a Cullin 1 complex that ubiquitinates Capicua following its phosphorylation by MAP kinase in response to Epidermal Growth Factor Receptor signaling. The CSN1b subunit also stabilizes unphosphorylated Capicua to control its basal level, independently of the deneddylase function of the complex. Here we further examine the importance of deneddylation for COP9 functions in vivo. We use an uncleavable form of Nedd8 to show that preventing deneddylation does not reproduce the effects of loss of COP9. In contrast, in the presence of COP9, conjugation to uncleavable Nedd8 renders Cullins unable to promote the degradation of their substrates. Our results suggest that irreversible neddylation prolongs COP9 binding to and inhibition of Cullin-based ubiquitin ligases.

Entities:  

Keywords:  COP9 signalosome; Cullin; Nedd8; ubiquitin ligase; wing disc

Mesh:

Substances:

Year:  2018        PMID: 29355077      PMCID: PMC6150624          DOI: 10.1080/19336934.2018.1429858

Source DB:  PubMed          Journal:  Fly (Austin)        ISSN: 1933-6934            Impact factor:   2.160


  67 in total

1.  Interactions of the COP9 signalosome with the E3 ubiquitin ligase SCFTIRI in mediating auxin response.

Authors:  C Schwechheimer; G Serino; J Callis; W L Crosby; S Lyapina; R J Deshaies; W M Gray; M Estelle; X W Deng
Journal:  Science       Date:  2001-05-03       Impact factor: 47.728

2.  The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation.

Authors:  Eric S Fischer; Andrea Scrima; Kerstin Böhm; Syota Matsumoto; Gondichatnahalli M Lingaraju; Mahamadou Faty; Takeshi Yasuda; Simone Cavadini; Mitsuo Wakasugi; Fumio Hanaoka; Shigenori Iwai; Heinz Gut; Kaoru Sugasawa; Nicolas H Thomä
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

3.  CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha.

Authors:  Katrin Schweitzer; Przemyslaw M Bozko; Wolfgang Dubiel; Michael Naumann
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

Review 4.  Moonlighting and pleiotropy within two regulators of the degradation machinery: the proteasome lid and the CSN.

Authors:  Elah Pick; Laylan Bramasole
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

5.  Distinct protein degradation mechanisms mediated by Cul1 and Cul3 controlling Ci stability in Drosophila eye development.

Authors:  Chan-Yen Ou; Yi-Fan Lin; Ying-Jiun Chen; Cheng-Ting Chien
Journal:  Genes Dev       Date:  2002-09-15       Impact factor: 11.361

Review 6.  The COP9 signalosome.

Authors:  Ning Wei; Xing Wang Deng
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

Review 7.  MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy.

Authors:  Steffan T Nawrocki; Patrick Griffin; Kevin R Kelly; Jennifer S Carew
Journal:  Expert Opin Investig Drugs       Date:  2012-07-16       Impact factor: 6.206

8.  Systematic in vivo RNAi analysis identifies IAPs as NEDD8-E3 ligases.

Authors:  Meike Broemer; Tencho Tenev; Kristoffer T G Rigbolt; Sophie Hempel; Blagoy Blagoev; John Silke; Mark Ditzel; Pascal Meier
Journal:  Mol Cell       Date:  2010-12-10       Impact factor: 17.970

9.  CSN6 drives carcinogenesis by positively regulating Myc stability.

Authors:  Jian Chen; Ji-Hyun Shin; Ruiying Zhao; Liem Phan; Hua Wang; Yuwen Xue; Sean M Post; Hyun Ho Choi; Jiun-Sheng Chen; Edward Wang; Zhongguo Zhou; Chieh Tseng; Christopher Gully; Guermarie Velazquez-Torres; Enrique Fuentes-Mattei; Giselle Yeung; Yi Qiao; Ping-Chieh Chou; Chun-Hui Su; Yun-Chih Hsieh; Shih-Lan Hsu; Kazufumi Ohshiro; Tattym Shaikenov; Huamin Wang; Sai-Ching Jim Yeung; Mong-Hong Lee
Journal:  Nat Commun       Date:  2014-11-14       Impact factor: 14.919

10.  CSN5/Jab1 mutations affect axis formation in the Drosophila oocyte by activating a meiotic checkpoint.

Authors:  Sergey Doronkin; Inna Djagaeva; Steven K Beckendorf
Journal:  Development       Date:  2002-11       Impact factor: 6.868

View more
  1 in total

1.  CSN1 facilitates proliferation and migration of hepatocellular carcinoma cells by upregulating cyclin A2 expression.

Authors:  Hangwei Fu; Yida Zhang; Yin Chen; Junying Chen; Ping Chen
Journal:  Mol Med Rep       Date:  2020-11-17       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.